Hazem Elkady

Cituota

	Visi	Nuo 2020
Šaltiniai	1975	1971
h-rodyklė	27	27
i10-rodyklė	48	48

740

370

185

555

2020202120222023202420259 94 376 644 721 124

Bendraautoriai

Ibrahim H. EissaProfessor, Faculty of pharmacy, Al-Azhar UniversityPatvirtintas el. paštas azhar.edu.eg
Eslam B. ElkaeedCollege of Pharmacy, Almaarefa UniversityPatvirtintas el. paštas um.edu.sa
Ahmed MetwalyAssociate Professor at faculty of Pharmacy, Al-Azhar University, Cairo, EgyptyPatvirtintas el. paštas azhar.edu.eg
Aisha Ali AlsfoukDepartment of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint AbdulrahmanPatvirtintas el. paštas pnu.edu.sa
Ibrahim M. IbrahimFaculty of Science, Cairo UniversityPatvirtintas el. paštas sci.cu.edu.eg
Reda G. yousefPhD , Faculty of Pharmacy, Al-Azhar UniversityPatvirtintas el. paštas azhar.edu.eg
taghour M. SPharmaceutical chemistry lecturePatvirtintas el. paštas azhar.edu.eg
Alaa ElwanFaculty of pharmacy - Al-Azhar university - Medicinal chemistry and drug design departmentPatvirtintas el. paštas azhar.edu.eg
Bshra Ali A. AlsfoukDepartment of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint AbdulrahmanPatvirtintas el. paštas pnu.edu.sa
Mohammed A. DahabAssociate Professor, Medicinal Chemistry Dep., Faculty of pharmacy, Al-Azhar UniversityPatvirtintas el. paštas azhar.edu.eg
Mohamed Ayman El-ZahabiMedicinal Chemistry department, Al Azhar University, Cairo, EgyptPatvirtintas el. paštas azhar.edu.eg
Dr.Nawaf Alsaifking Saud UniversityPatvirtintas el. paštas ksu.edu.sa
Wagdy M. EldehnaAssociate Professor of Pharmaceutical Chemistry, Faculty of Pharmacy, Kafrelsheikh University, EgyptPatvirtintas el. paštas pharm.kfs.edu.eg
Khaled El-AdlProfessorPatvirtintas el. paštas Azhar.edu.eg
Mohammed Saad AlesawyAssociate professor of Medicinal Chemistry and Drug Design, Faculty of Pharmacy, Al-Azhar universityPatvirtintas el. paštas azhar.edu.eg
Abdallah E. AbdallahLecturer of Medicinal Chemistry, Faculty of Pharmacy, Al-Azhar UniversityPatvirtintas el. paštas azhar.edu.eg
Nehal Mohammed EL DeebAssociate prof. of biopharmaceutical product, Genetic engineering and biotechnology researchPatvirtintas el. paštas iu.edu
Hesham A. El-MahdyLecturer of Clinical Biochemistry and Molecular Biology (Ph.D.), Faculty of Pharmacy, Al-Azhar Univ.Patvirtintas el. paštas azhar.edu.eg
Amany BelalProfessor of Pharmaceutical Chemistry, Faculty of pharmacy, Taif UniversityPatvirtintas el. paštas tu.edu.sa
Ahmed A. Al-KarmalawyAssociate Professor of Medicinal Chemistry, University of MashreqPatvirtintas el. paštas horus.edu.eg

Stebėti

Hazem Elkady

Associate professor of Pharmaceutical Medicinal Chemistry and Drug Design Department

Patvirtintas el. paštas azhar.edu.eg

chemistry drug design molecular modeling


Pavadinimas Rūšiuoti pagal šaltinius Rūšiuoti pagal metus Rūšiuoti pagal pavadinimą	Cituota Cituota	Metai
New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: Design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and in silico studies H Elkady, A Elwan, HA El-Mahdy, AS Doghish, A Ismail, MS Taghour, ... Journal of enzyme inhibition and medicinal chemistry 37 (1), 403-416, 2022	111	2022
Discovery of thieno [2, 3-d] pyrimidine-based derivatives as potent VEGFR-2 kinase inhibitors and anti-cancer agents SA El-Metwally, MM Abou-El-Regal, IH Eissa, ABM Mehany, HA Mahdy, ... Bioorganic Chemistry 112, 104947, 2021	96	2021
Design, synthesis, docking, DFT, MD simulation studies of a new nicotinamide-based derivative: In vitro anticancer and VEGFR-2 inhibitory effects EB Elkaeed, RG Yousef, H Elkady, IMM Gobaara, BA Alsfouk, DZ Husein, ... Molecules 27 (14), 4606, 2022	95	2022
Design, synthesis, and biological evaluation of new challenging thalidomide analogs as potential anticancer immunomodulatory agents MA El-Zahabi, H Sakr, K El-Adl, M Zayed, AS Abdelraheem, SI Eissa, ... Bioorganic chemistry 104, 104218, 2020	95	2020
Design and synthesis of thiazolidine-2, 4-diones hybrids with 1, 2-dihydroquinolones and 2-oxindoles as potential VEGFR-2 inhibitors: In-vitro anticancer evaluation and in … MS Taghour, H Elkady, WM Eldehna, NM El-Deeb, AM Kenawy, ... Journal of Enzyme Inhibition and Medicinal Chemistry 37 (1), 1903-1917, 2022	89	2022
New quinoxaline derivatives as VEGFR-2 inhibitors with anticancer and apoptotic activity: Design, molecular modeling, and synthesis NA Alsaif, MA Dahab, MM Alanazi, AJ Obaidullah, AA Al-Mehizia, ... Bioorganic Chemistry 110, 104807, 2021	87	2021
Design, synthesis, docking, ADMET studies, and anticancer evaluation of new 3-methylquinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers MM Alanazi, IH Eissa, NA Alsaif, AJ Obaidullah, WA Alanazi, AF Alasmari, ... Journal of Enzyme Inhibition and Medicinal Chemistry 36 (1), 1760-1782, 2021	82	2021
Design, synthesis, in silico ADMET profile and GABA‐A docking of novel phthalazines as potent anticonvulsants AGA El‐Helby, RRA Ayyad, MF Zayed, HS Abulkhair, H Elkady, K El‐Adl Archiv Der Pharmazie 352 (5), 1800387, 2019	61	2019
New quinoxaline-based VEGFR-2 inhibitors: Design, synthesis, and antiproliferative evaluation with in silico docking, ADMET, toxicity, and DFT studies MM Alanazi, H Elkady, NA Alsaif, AJ Obaidullah, HM Alkahtani, ... RSC advances 11 (48), 30315-30328, 2021	58	2021
Phthalazine-1, 4-dione derivatives as non-competitive AMPA receptor antagonists: design, synthesis, anticonvulsant evaluation, ADMET profile and molecular docking AGA El-Helby, RRA Ayyad, K El-Adl, H Elkady Molecular diversity 23, 283-298, 2019	58	2019
Multi-step in silico discovery of natural drugs against COVID-19 targeting main protease EB Elkaeed, FS Youssef, IH Eissa, H Elkady, AA Alsfouk, ML Ashour, ... International Journal of Molecular Sciences 23 (13), 6912, 2022	57	2022
Design and synthesis of new 4-(2-nitrophenoxy) benzamide derivatives as potential antiviral agents: Molecular modeling and in vitro antiviral screening AE Abdallah, MS Alesawy, SI Eissa, EM El-Fakharany, MH Kalaba, ... New Journal of Chemistry 45 (36), 16557-16571, 2021	56	2021
Discovery of new VEGFR-2 inhibitors based on bis([1, 2, 4]triazolo)[4,3-a:3',4'-c]quinoxaline derivatives as anticancer agents and apoptosis inducers NA Alsaif, MS Taghour, MM Alanazi, AJ Obaidullah, AA Al-Mehizia, ... Journal of enzyme inhibition and medicinal chemistry 36 (1), 1093-1114, 2021	54	2021
Design, synthesis, in vitro biological assessment and molecular modeling insights for novel 3-(naphthalen-1-yl)-4, 5-dihydropyrazoles as anticancer agents with potential EGFR … WM Eldehna, MA El Hassab, ZM Elsayed, T Al-Warhi, H Elkady, ... Scientific reports 12 (1), 12821, 2022	50	2022
A multistage in silico study of natural potential inhibitors targeting SARS-CoV-2 main protease EB Elkaeed, IH Eissa, H Elkady, A Abdelalim, AM Alqaisi, AA Alsfouk, ... International Journal of Molecular Sciences 23 (15), 8407, 2022	49	2022
The Assessment of Anticancer and VEGFR-2 Inhibitory Activities of a New 1H-Indole Derivative: In Silico and In Vitro Approaches EB Elkaeed, RG Yousef, H Elkady, IMM Gobaara, AA Alsfouk, DZ Husein, ... Processes 10 (7), 1391, 2022	46	2022
Discovery of new quinoxaline-based derivatives as anticancer agents and potent VEGFR-2 inhibitors: Design, synthesis, and in silico study MM Alanazi, H Elkady, NA Alsaif, AJ Obaidullah, WA Alanazi, ... Journal of Molecular Structure 1253, 132220, 2022	45	2022
Modified benzoxazole-based VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, and anti-proliferative evaluation A Elwan, AE Abdallah, HA Mahdy, MA Dahab, MS Taghour, EB Elkaeed, ... Molecules 27 (15), 5047, 2022	44	2022
Design, synthesis and molecular docking of new fused 1H-pyrroles, pyrrolo[3,2-d]pyrimidines and pyrrolo[3,2-e][1, 4]diazepine derivatives as potent EGFR/CDK2 … A Belal, NM Abdel Gawad, ABM Mehany, MAS Abourehab, H Elkady, ... Journal of enzyme inhibition and medicinal chemistry 37 (1), 1884-1902, 2022	42	2022
Multi-phase in silico discovery of potential SARS-CoV-2 RNA-dependent RNA polymerase inhibitors among 3009 clinical and FDA-approved related drugs EB Elkaeed, H Elkady, A Belal, BA Alsfouk, TH Ibrahim, M Abdelmoaty, ... Processes 10 (3), 530, 2022	42	2022

Sistema negali atlikti operacijos. Bandykite vėliau dar kartą.

Straipsniai 1–20

Šaltinių per metus

Dubliuoti šaltiniai

Sujungti šaltiniai

Pridėti bendraautoriusBendraautoriai

Stebėti

Cituota

Bendraautoriai